Search hospitals > Colorado > Denver
Presbyterian - Saint Lukes Medical Center - Health One
Claim this profileDenver, Colorado 80218
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Leukemia
Conducts research for Lung Cancer
Conducts research for Lymphoma
360 reported clinical trials
5 medical researchers
Summary
Presbyterian - Saint Lukes Medical Center - Health One is a medical facility located in Denver, Colorado. This center is recognized for care of Cancer, Breast Cancer, Leukemia, Lung Cancer, Lymphoma and other specialties. Presbyterian - Saint Lukes Medical Center - Health One is involved with conducting 360 clinical trials across 488 conditions. There are 5 research doctors associated with this hospital, such as Nicholas DiBella, Alireza Eghtedar, Peter McSweeney, MD, and Keren Sturtz.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder5 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
103 reported clinical trials
193 drugs studied
Alireza EghtedarColorado Blood Cancer Institute2 years of reported clinical research
Studies Acute Myeloid Leukemia
Studies Leukemia
11 reported clinical trials
24 drugs studied
Peter McSweeney, MDColorado Blood Cancer Institute6 years of reported clinical research
Studies Lymphoma
Studies Multiple Myeloma
6 reported clinical trials
9 drugs studied
Keren SturtzSCL Health Lutheran Medical Center9 years of reported clinical research
Studies Breast Cancer
Studies Carcinoma
4 reported clinical trials
14 drugs studied
Clinical Trials running at Presbyterian - Saint Lukes Medical Center - Health One
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Melanoma
Cancer
Cutaneous Melanoma
Skin Cancer
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Mobile Health
for Breast Cancer
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Recruiting1 award N/A10 criteria
Cognitive Training
for Breast Cancer Survivors
This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
Recruiting1 award N/A5 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Presbyterian - Saint Lukes Medical Center - Health One?
Presbyterian - Saint Lukes Medical Center - Health One is a medical facility located in Denver, Colorado. This center is recognized for care of Cancer, Breast Cancer, Leukemia, Lung Cancer, Lymphoma and other specialties. Presbyterian - Saint Lukes Medical Center - Health One is involved with conducting 360 clinical trials across 488 conditions. There are 5 research doctors associated with this hospital, such as Nicholas DiBella, Alireza Eghtedar, Peter McSweeney, MD, and Keren Sturtz.
Where is Presbyterian - Saint Lukes Medical Center - Health One located?
**Presbyterian/St. Luke's Medical Center**
- **Address:** 1719 E 19th Ave, Denver, CO 80218
- **Directions:** Accessible via I-25 N, exit 205B for 20th Ave.
- **Hours:** Open 24/7
- **Services Offered:** Emergency care, surgery, women's health, cancer care, orthopedics, cardiology, neurology, and pediatrics.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at Presbyterian - Saint Lukes Medical Center - Health One:
- **Pricing Estimates & Prospective Services:** Call (800) 370-1983.
- **Billing Questions:** Refer to the customer service number on your statement.
- **Assistance for Uninsured/Underinsured:** Call 505-841-1406.
For more details, visit the HealthOne Cares and Presbyterian Healthcare Services websites.
What insurance does Presbyterian - Saint Lukes Medical Center - Health One accept?
Presbyterian - Saint Lukes Medical Center - Health One and its affiliated entities, including HealthONE Presbyterian/St.Luke's Medical Center and Saint Luke's Hospital, accept a wide range of insurance plans. These include commercial/group products, Medicare Advantage, managed Medicaid/Centennial Care, Medicaid, Medicare-Denver Boulder, Senior plans, and plans from Aetna, Blue Cross Blue Shield, Cigna, Humana, and United Healthcare. It is recommended to verify insurance coverage with the specific hospital or healthcare provider before receiving services.
What awards or recognition has Presbyterian - Saint Lukes Medical Center - Health One received?
Presbyterian/St. Luke's Medical Center, part of HealthONE in Denver, Colorado, has been named the top large health system by IBM Watson Health for two consecutive years. It ranks as the top hospital in Colorado and #46 in the US for cancer care by U.S. News & World Report in 2023. The hospital is a pioneer in medical advancements, including the first heart transplant in 1985, the first bone marrow transplant in 1991, and introducing robotic surgery to Denver and the surrounding regions in 2003.